Azizidoost et al. demonstrated that inhibiting microRNA-23 (miR-23) prevents myocardial ischemia/reperfusion injury (MIRI) by upregulating acetyl hyaluronan synthase 2 (Has2) expression, promoting bone marrow mesenchymal stem cell (BMSC) differentiation into cardiomyocytes, possibly through Wnt pathway activation [38]. The gene discussed is HAS2; the disease is myocardial ischemia.